http://www.acc.org/Feed?clinicalTopicID=f24e6d2b-ba21-4c56-871d-d44e86eba30b Clinical Topic Feed: Cardiac Surgery and VHD en /Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026 In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM). 1782910140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/PARTNER-3 TAVR and surgery demonstrated comparable and sustained valve durability in low-risk patients with symptomatic severe aortic stenosis (AS), with both approaches showing low and similar rates of structural valve deterioration (SVD), all-cause bioprosthetic valve failure (BVF) and reintervention through seven years... 1782845400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/PARTNER-2A-P2S3i-Registry The rates of mortality and reintervention at 10 years were higher in patients at intermediate risk who underwent TAVR with the second-generation SAPIEN XT valve than those who underwent surgery in the PARTNER 2A trial, according to an analysis published June 16 in a valvular heart disease focus issue of JACC. 1782399420000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/17/17/38/CMS-Proposes-Updates-to-TAVR-National-Coverage-Determination The Centers for Medicare and Medicaid Services (CMS) released a proposed decision memo on the National Coverage Determination (NCD) for TAVR, introducing changes to coverage pathways, evidence development and quality oversight. 1781718060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Feature-Navigating-Valve-Disease Shared decision-making has become central to the management of valve disease, including tricuspid regurgitation (TR) (see cover story) and severe aortic stenosis (AS). If done correctly, it can help clinicians engage patients and families in meaningful discussions about symptoms, prognosis, treatment burden and personal goals... 1780316280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/26/13/15/Evolut-Low-Risk-Trial-Six-Year-Outcomes The Evolut Low Risk trial was a prospective randomized trial that enrolled patients at low surgical risk with severe trileaflet aortic stenosis from 87 international sites between 2016 and 2019. 1779899100000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/JACC-Journals-Science-From-EuroPCR-2026 Findings from four late-breaking clinical trials presented at EuroPCR 2026 in Paris, France, were simultaneously published in JACC: Cardiovascular Interventions. Together they lend new insights into residual tricuspid regurgitation (TR) after tricuspid valve transcatheter edge-to-edge repair (T-TEER), the safety of transfemoral (TF) transcatheter mitral valve replacement (TMVR), the novel BATMAN-TMVR technique, and the effect of implant depth on TAVR outcomes. 1779371700000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/22/49/Joint-Statement The Society for Cardiovascular Angiography & Interventions (SCAI), American College of Cardiology (ACC), and Society of Thoracic Surgeons (STS), on May 1, released the following joint statement in response to recent media coverage about Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR):... 1777679520000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/21/15/23/ACC26-Structural-Intervention-Trials-Offer-Viable-Options Late-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach... 1776939000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/22/13/48/eagles-eye-view-22apr2026 In this week’s Eagle's Eye View, Dr. Eagle examines early surgery for asymptomatic patients with severe aortic stenosis. 1776865800000 Articles and Stories